Myriad Genetics
MYGN
MYGN
220 hedge funds and large institutions have $481M invested in Myriad Genetics in 2025 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 91 increasing their positions, 54 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
14% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 49
42% less capital invested
Capital invested by funds: $833M → $481M (-$353M)
Holders
220
Holding in Top 10
–
Calls
$2.45M
Puts
$105K
Top Buyers
| 1 | +$15.6M | |
| 2 | +$10.6M | |
| 3 | +$7.15M | |
| 4 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
+$6.64M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.24M |
Top Sellers
| 1 | -$40.7M | |
| 2 | -$35.3M | |
| 3 | -$21.4M | |
| 4 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$21.1M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$20.2M |
